Lantern Pharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $100 | $100 | $0 |
Gross Profit | -4 | -4 | 50 | -47 |
EBITDA | -4,651 | -4,769 | -5,891 | -5,175 |
EBIT | -4,656 | -4,774 | -5,896 | -5,179 |
Net Income | -4,331 | -4,536 | -5,875 | -4,505 |
Net Change In Cash | 0 | 100 | 100 | 0 |
Free Cash Flow | -3,937 | -4,376 | -3,974 | -5,585 |
Cash | 6,061 | 6,377 | 7,511 | 8,102 |
Basic Shares | 10,784 | 10,784 | 10,784 | 10,763 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -190 | -174 | -154 | -97 |
EBITDA | -20,590 | -15,786 | -14,422 | -12,265 |
EBIT | -20,781 | -15,961 | -14,432 | -12,363 |
Net Income | -20,781 | -15,961 | -14,259 | -12,363 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -14,770 | |||
Free Cash Flow | -17,825 | -14,365 | -12,795 | -10,607 |
Cash | 7,511 | 21,937 | 37,201 | 51,524 |
Basic Shares | 10,762 | 10,842 | 10,850 | 10,904 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.40 |
2025-03-31 | -$0.42 |
2024-12-31 | -$0.54 |
